Premenstrual Syndrome Market Size And Share

Report Code : TIPRE00008488
Category : Life Sciences

No. of Pages : 150

Buy Now

Principales conclusions et analyse des parts de marché du syndrome prémenstruel d'ici 2025-2031

Buy Now

Premenstrual Syndrome Market Report Analysis

Premenstrual Syndrome Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Alva-Amco Pharmacal Cos., Inc
Bayer, Inc.
Bristol-Myers Squibb Company
Chattem, Inc. (Sanofi)
DEKK-TEC, Inc.
GlaxoSmithKline Plc
MetP Pharma AG
Novartis AG
Pherin Pharmaceuticals, Inc.

Regional Overview

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et centrale
Moyen-Orient et Afrique

Market Segmentation

By Type de traitement

analgésiques
pilules contraceptives orales
patchs et implants à base d'œstrogènes seuls
analogues de la gonadolibérine

By Géographie

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et Centrale